ABSTRACT APDM's Mobility Lab system provides portable, validated, reliable, objective
measures of balance and gait that are sensitive to Parkinson's disease (PD). In this review …

Background: The emergence of new technologies measuring outcomes in Parkinson's
disease (PD) to complement the existing clinical rating scales has introduced the possibility …

Objective Across all stages of Alzheimer disease (AD), apathy is the most common
neuropsychiatric symptom. Studies using the Neuropsychiatric Inventory (NPI) have found …

Body weight gain in combination with metabolic alterations has been observed after deep
brain stimulation (DBS) of subthalamic nucleus (STN) in patients with Parkinson's disease …

With the progress of technologies of recent years, methods have become available that use
wearable sensors and ambulatory systems to measure aspects of–particular axial–motor …

Abstract Study Objectives We conducted a prospective study to quantify motor activity during
sleep measured by actigraphy before and after 3 months of treatment with clonazepam in …

Unconstrained human movement can be broken down into a series of stereotyped motifs or
'syllables' in an unsupervised fashion. Sequences of these syllables can be represented by …

Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is the “gold-
standard” tool in assessing the severity of symptoms in patients with Parkinson's disease …

Although Levodopa-induced dyskinesias (LID) are one of the most compromising
complications of dopaminergic treatment in Parkinson's disease (PD), there is no widely …

Introduction: Wearable accelerometers can be used to evaluate waking and sleeping
movements. Although a correlation between accelerometer data captured at the wrist and …